Compare Enveric Biosciences Inc (ENVB) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Viking Holdings Ltd Ordinary Shares — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.46B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 5361.8× Enveric Biosciences Inc's market cap, and Viking Holdings Ltd Ordinary Shares is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| ENVB | VIK | |
|---|---|---|
Market Cap | $6.80M | $36.46B |
Volume | 64,867 | 3,461,906 |
Sector | Health | Consumer Cyclical |
52-Week High | $10.80 | $108.26 |
52-Week Low | $1.27 | $57.08 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | -$1.49M | $38.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Viking Holdings Ltd Ordinary Shares
Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →
